Fred R. Hirsch, MD, PhD

University of Colorado, Denver, Colorado, USA

Fred Hirsch is Professor of Medicine and Pathology, University of Colorado, Denver, Colorado, USA and Chief Executive Officer of IASLC.

Professor Hirsch received his MD and PhD from the University of Copenhagen, Denmark. After training in pathology and medical oncology in Copenhagen, he served from 1996-1999 as chief physician (“overlaege”) at the Department of Oncology of the Finsen Center, Rigshospitalet in Copenhagen. From 1999-2002 he was Visiting Professor at the University of Colorado Cancer Center and since 2012 Professor of Medicine and from 2004 also Professor of Pathology at the University of Colorado. Professor Hirsch has extensive teaching experience and has been a supervisor for many European and Asian post-doctoral trainees in his lab at the University of Colorado Cancer Center.

As an active researcher, he has received numerous grants. His main interest involves research into development and clinical implementation of biomarkers for early detection and therapy in non-small cell lung cancer (NSCLC). Professor Hirsch is a recipient of the Mary J Matthews Distinguished Scientific Award, presented by the International Association for the Study of Lung Cancer (IASLC). He has been in the Board of Directors for IASLC and is now the Chief Executive Director of IASLC. He has been an active member of other scientific and professional bodies, particularly the American Society of Clinical Oncology. He has also been involved in many international symposia and meetings, either as presiding over, or being a member of the organizing committees or as an invited speaker. He has served as member of NCI Steering Committee for Thoracic Malignancies and is currently Chair of NCI/FDA Task Force for developing “Master protocols in Lung Cancer”.

Professor Hirsch is Associate Editor of Journal of Thoracic Oncology, and section editor of The Oncologist. He is an editorial board member of many oncology journals. He is widely published, having authored 10 books, 30 book chapters and more than 250 peer-reviewed manuscripts.